Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Change in Cash (2015 - 2026)

Cellectis (CLLS) posted quarterly Change in Cash of -$26.5 million for Q1 2026, down 55.48% year-over-year from -$59.5 million in Q1 2025, and down 433.06% quarter-over-quarter from $7.9 million in Q4 2025.

Analysis

Cellectis (CLLS) Change in Cash (2015 - 2026) Analysis & Trends

Cellectis' Change in Cash history runs 12 years deep, the most recent figure standing at -$26.5 million for Q1 2026.

  • In Q1 2026, Change in Cash fell 55.48% year-over-year to -$26.5 million; the TTM figure through Mar 2026 stood at -$95.1 million (down 1757.56% YoY), while the FY2025 annual figure was -$85.6 million, down 1021.43% from the prior year.
  • Change in Cash for Q1 2026 stood at -$26.5 million, down from $7.9 million in the prior quarter.
  • The five-year high for Change in Cash was $67.6 million in Q4 2023, with the low at -$67.3 million in Q2 2025.
  • The 5-year median for Change in Cash is -$13.5 million (2024), against an average of -$8.8 million.
  • The sharpest annual moves came in 2024 and 2025: Change in Cash surged 2495.06% in 2024, then plunged 377.38% in 2025.
  • Cellectis' Change in Cash stood at -$6.4 million in 2022, then surged by 1152.81% to $67.6 million in 2023, then tumbled by 120.37% to -$13.8 million in 2024, then surged by 157.68% to $7.9 million in 2025, then slumped by 433.06% to -$26.5 million in 2026.
  • Business Quant data shows CLLS's Change in Cash at -$26.5 million in Q1 2026, $7.9 million in Q4 2025, and -$9.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Cellectis 321.90 Mn 155.05 Mn - 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18 Mn
Mar 31, 2026 -26.48 Mn
Dec 31, 2025 7.95 Mn
Sep 30, 2025 -9.27 Mn
Jun 30, 2025 -67.30 Mn
Mar 31, 2025 -17.03 Mn
Dec 31, 2024 120.17 Mn
Sep 30, 2024 12.29 Mn
Jun 30, 2024 24.26 Mn
Mar 31, 2024 -13.47 Mn
Dec 31, 2023 69.35 Mn
Sep 30, 2023 76.69 Mn
Jun 30, 2023 -92.84 Mn
Mar 31, 2023 83.52 Mn
Dec 31, 2022 -828,000.00
Sep 30, 2022 143.03 Mn
Jun 30, 2022 -189.99 Mn
Mar 31, 2022 137.58 Mn
Dec 31, 2021 198.86 Mn
Sep 30, 2021 -36.57 Mn